Incidence, Mortality, and Trends of Nonmelanoma Skin Cancer in Germany

Journal of Investigative Dermatology

Volumn 137, Issue 9, 2017, Pages 1860-1867

  Leiter, Ulrike ^a   Keim, Ulrike ^a   Eigentler, Thomas ^a   Katalinic, Alexander ^b   Holleczek, Bernd ^c   Martus, Peter ^a   Garbe, Claus ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^c SAARLAND CANCER REGISTRY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AGE DISTRIBUTION; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; FACTUAL DATABASE; FEMALE; GERMANY; HUMAN; INCIDENCE; MALE; REGISTER; RETROSPECTIVE STUDY; RISK ASSESSMENT; SEX RATIO; SKIN NEOPLASMS; SURVIVAL ANALYSIS;

AGE DISTRIBUTION; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; DATABASES, FACTUAL; FEMALE; GERMANY; HUMANS; INCIDENCE; MALE; REGISTRIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEX DISTRIBUTION; SKIN NEOPLASMS; SURVIVAL ANALYSIS;

EID: 85028348225     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1016/j.jid.2017.04.020     Document Type: Article

References (40)

1. Augustin, M., Stadler, R., Reusch, M., Schafer, I., Kornek, T., Luger, T., Skin cancer screening in Germany—perception by the public. J Dtsch Dermatol Ges 10 (2012), 42–49.
2. Autier, P., Boniol, M., Dore, J.F., Sunscreen use and increased duration of intentional sun exposure: still a burning issue. Int J Cancer 121 (2007), 1–5.
3. Birch-Johansen, F., Jensen, A., Mortensen, L., Olesen, A.B., Kjaer, S.K., Trends in the incidence of nonmelanoma skin cancer in Denmark 1978-2007: rapid incidence increase among young Danish women. Int J Cancer 127 (2010), 2190–2198.
4. Brewster, D.H., Bhatti, L.A., Inglis, J.H., Nairn, E.R., Doherty, V.R., Recent trends in incidence of nonmelanoma skin cancers in the East of Scotland, 1992-2003. Br J Dermatol 156 (2007), 1295–1300.
5. de Vries, E., van de Poll-Franse, L.V., Louwman, W.J., de Gruijl, F.R., Coebergh, J.W., Predictions of skin cancer incidence in the Netherlands up to 2015. Br J Dermatol 152 (2005), 481–488.
6. Donaldson, M.R., Coldiron, B.M., No end in sight: the skin cancer epidemic continues. Semin Cutan Med Surg 30 (2011), 3–5.
7. Dyba, T., Hakulinen, T., Comparison of different approaches to incidence prediction based on simple interpolation techniques. Stat Med 19 (2000), 1741–1752.
8. Eisemann, N., Waldmann, A., Garbe, C., Katalinic, A., Development of a microsimulation of melanoma mortality for evaluating the effectiveness of population-based skin cancer screening. Med Decis Making 35 (2015), 243–254.
9. Eisemann, N., Waldmann, A., Geller, A.C., Weinstock, M.A., Volkmer, B., Greinert, R., et al. Non-melanoma skin cancer incidence and impact of skin cancer screening on incidence. J Invest Dermatol 134 (2014), 43–50.
10. Garbe, C., Leiter, U., Melanoma epidemiology and trends. Clin Dermatol 27 (2009), 3–9.
11. Hakulinen, T., Dyba, T., Precision of incidence predictions based on Poisson distributed observations. Stat Med 13 (1994), 1513–1523.
12. Hollestein, L.M., de Vries, E., Nijsten, T., Trends of cutaneous squamous cell carcinoma in the Netherlands: Increased incidence rates, but stable relative survival and mortality 1989-2008. Eur J Cancer 48 (2012), 2046–2053.
13. Jensen, A., Birch-Johansen, F., Olesen, A.B., Christensen, J., Tjonneland, A., Kjaer, S.K., Intake of alcohol may modify the risk for non-melanoma skin cancer: results of a large Danish prospective cohort study. J Invest Dermatol 132 (2012), 2718–2726.
14. Jensen, A.O., Bautz, A., Olesen, A.B., Karagas, M.R., Sorensen, H.T., Friis, S., Mortality in Danish patients with nonmelanoma skin cancer, 1978-2001. Br J Dermatol 159 (2008), 419–425.
15. Katalinic, A., Kunze, U., Schafer, T., Epidemiology of cutaneous melanoma and non-melanoma skin cancer in Schleswig-Holstein, Germany: incidence, clinical subtypes, tumour stages and localization (epidemiology of skin cancer). Br J Dermatol 149 (2003), 1200–1206.
16. Keim, U., van der Pols, J.C., Williams, G.M., Green, A.C., Exclusive development of a single type of keratinocyte skin cancer: evidence from an Australian population-based cohort study. J Invest Dermatol 135 (2015), 728–733.
17. Kim, H.J., Fay, M.P., Feuer, E.J., Midthune, D.N., Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 19 (2000), 335–351.
18. Kim, R.H., Armstrong, A.W., Nonmelanoma skin cancer. Dermatol Clin 30 (2012), 125–139.
19. Leiter, U., Eigentler, T., Garbe, C., Epidemiology of skin cancer. Adv Exp Med Biol 810 (2014), 120–140.
20. Lewis, K.G., Weinstock, M.A., Nonmelanoma skin cancer mortality (1988-2000): the Rhode Island follow-back study. Arch Dermatol 140 (2004), 837–842.
21. Lewis, K.G., Weinstock, M.A., Trends in nonmelanoma skin cancer mortality rates in the United States, 1969 through 2000. J Invest Dermatol 127 (2007), 2323–2327.
22. Lomas, A., Leonardi-Bee, J., Bath-Hextall, F., A systematic review of worldwide incidence of nonmelanoma skin cancer. Br J Dermatol 166 (2012), 1069–1080.
23. Moller, B., Fekjaer, H., Hakulinen, T., Tryggvadottir, L., Storm, H.H., Talback, M., et al. Prediction of cancer incidence in the Nordic countries up to the year 2020. Eur J Cancer Prev 11:Suppl. 1 (2002), S1–S96.
24. Muir, C.S., Percy, C., Cancer registration: principles and methods. Classification and coding of neoplasms. IARC Sci Publ 95 (1991), 64–81.
25. Nguyen-Nielsen, M., Wang, L., Pedersen, L., Olesen, A.B., Hou, J., Mackey, H., et al. The incidence of metastatic basal cell carcinoma (mBCC) in Denmark, 1997-2010. Eur J Dermatol 25 (2015), 463–468.
26. Nikolaou, V., Stratigos, A.J., Emerging trends in the epidemiology of melanoma. Br J Dermatol 170 (2014), 11–19.
27. Revenga Arranz, F., Paricio Rubio, J.F., Mar Vazquez Salvado, M., del Villar Sordo, V., Descriptive epidemiology of basal cell carcinoma and cutaneous squamous cell carcinoma in Soria (north-eastern Spain) 1998-2000: a hospital-based survey. J Eur Acad Dermatol Venereol 18 (2004), 137–141.
28. Robert Koch Institute. Gesellschaft, der epidemiologischen Krebsregister in Deutschland e.V. Krebs in Deutschland 2011/2012. 10. Ausgabe; 2015 (accessed 15 September 2016).
29. Rogers, H.W., Weinstock, M.A., Feldman, S.R., Coldiron, B.M., Incidence estimate of nonmelanoma skin cancer (keratinocyte carcinomas) in the US population, 2012. JAMA Dermatol 151 (2015), 1081–1086.
30. Rudolph, C., Schnoor, M., Eisemann, N., Katalinic, A., Incidence trends of nonmelanoma skin cancer in Germany from 1998 to 2010. J Dtsch Dermatol Ges 13 (2015), 788–797.
31. Saarland Cancer Registry. http://www.krebsregister.saarland.de/datenbank/datenbank.html; 2016 (accessed 16 September 2016).
32. Schleswig Holstein cancer registry. http://www.cancer-sh.de/datenbank/index.html; 2016 (accessed 16 September 2016).
33. Sekulic, A., Migden, M.R., Oro, A.E., Dirix, L., Lewis, K.D., Hainsworth, J.D., et al. Efficacy and safety of vismodegib in advanced basal-cell carcinoma. N Engl J Med 366 (2012), 2171–2179.
34. Stang, A., Genital and nongenital nonmelanoma skin cancer: more epidemiological studies are needed. J Invest Dermatol, 127, 2007, 229609.
35. Stang, A., Jockel, K.H., Declining mortality rates for nonmelanoma skin cancers in West Germany, 1968-99. Br J Dermatol 150 (2004), 517–522.
36. Statistisches Bundesamt. https://www.destatis.de/DE/ZahlenFakten/GesellschaftStaat/Bevoelkerung/Bevoelkerung.html; 2016 (accessed 16 September 2016).
37. Tejera-Vaquerizo, A., Descalzo-Gallego, M.A., Otero-Rivas, M.M., Posada-Garcia, C., Rodriguez-Pazos, L., Pastushenko, I., et al. Skin cancer incidence and mortality in Spain: a systematic review and meta-analysis. Actas Dermosifiliogr 10 (2016), 318–328.
38. Trakatelli, M., Ulrich, C., del, M.V., Euvrard, S., Stockfleth, E., Abeni, D., Epidemiology of nonmelanoma skin cancer (NMSC) in Europe: accurate and comparable data are needed for effective public health monitoring and interventions. Br J Dermatol 156:Suppl. 3 (2007), 1–7.
39. Waldmann, A., Nolte, S., Geller, A.C., Katalinic, A., Weinstock, M.A., Volkmer, B., et al. Frequency of excisions and yields of malignant skin tumors in a population-based screening intervention of 360,288 whole-body examinations. Arch Dermatol 148 (2012), 903–910.
40. Waldmann, A., Nolte, S., Weinstock, M.A., Breitbart, E.W., Eisemann, N., Geller, A.C., et al. Skin cancer screening participation and impact on melanoma incidence in German—-an observational study on incidence trends in regions with and without population-based screening. Br J Cancer 106 (2012), 970–974.